NEWS
ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements
ImmunoPrecise Antibodies (IPA), an AI-driven biotherapeutics company, has received a notification from Nasdaqregarding non-compliance with the minimum bid price requirement. The notification, received on August 19, 2024, states that IPA's common shares closed below $1.00 for 30 consecutive business days from July 5 to August 15, 2024, violating Nasdaq Rule 5450(a)(1). This notification does not immediately affect IPA's listing or trading status on Nasdaq and is not a notice of imminent delisting. The company now has a specified period to regain compliance by meeting the minimum bid price requirement.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1659Followers
91Following
13KVisitors
Follow